Alvogen  

Morristown,  NJ 
United States
http://www.alvogenteriparatide.com
  • Booth: 1438


Alvogen's Teriparatide Injection 620 mcg/2.48 mL (250mcg/mL)

Alvogen is a privately owned US-based company focused on developing, in-licensing, manufacturing and marketing pharmaceutical products.  Alvogen’s Teriparatide Injection is the first FDA-approved teriparatide alternative to Forteo®*.  Teriparatide Injection delivers proven clinical experience and affordability to help your patients at high risk for fracture increase bone density.

Teriparatide Injection is a medication designed to assist in building new bone, and is comprised of protein similar to one naturally produced by the body. It has also been shown to help increase bone strength.†

Teriparatide Injection helps to grow healthy bones by increasing bone mineral density and bone strength, which may prevent fractures.

For Full Prescribing Information, including Medication Guide and User Manual, please visit www.alvogenteriparatide.com.

* Not automatically substituted for Forteo.
† Only proven in postmenopausal women with osteoporosis.

Brands: Teriparatide Injection 620 mcg/2.48 mL (250 mcg/mL) 20 mcg per dose


 Products

  • Teriparatide Injection 620 mcg/2.48 mL (250mcg/ml)
    The first FDA-approved teriparatide alternative to Forteo®*
    * Not automatically substituted for Forteo....

  • Discover a lower cost option for your patients.†  The first FDA-approved teriparatide alternative to Forteo®*

    Teriparatide Injection is a medication designed to assist in building new bone, and is comprised of protein similar to one naturally produced by the body. It has also been shown to help increase bone strength.**

    Teriparatide Injection helps to grow healthy bones by increasing bone mineral density and bone strength, which may prevent fractures. 

    74% of all US covered lives have access to Alvogen's Teriparatide Injection.1 

    To ensure your patients get Alvogen's Teriparatide Injection, choose Teriparatide Injection 620 mcg/2.48 mL (250 mcg/mL) in your electronic health records (EHR) system.

    For Full Prescribing Information, including Medication Guide and User Manual, please visit www.alvogenteriparatide.com.

     

    † Savings based on WAC.

    * Not automatically substituted for Forteo.

    ** Only proven in postmenopausal women with osteoporosis.

    1 MMIT February 2024, Data on file.